Epilepsy Market Size, Segments, and Trends by 2031
Epilepsy Market: Strategic Insights
Epilepsy Market
-
CAGR (2022 - 2030)4.1% -
Market Size 2022
US$ 7.7 Billion -
Market Size 2030
US$ 10.7 Billion
Market Dynamics
GROWTH DRIVERS
- Growing Awareness Programs Conducted by Various Government and Private Organization about Increase in Epilepsy Diagnoses and Treatments offering Lucrative Growth Opportunities to the Market.
FUTURE TRENDS
- Cell and Gene Therapy Approaches for the treatment of Epilepsy
OPPORTUNITIES
- Gene Therapy is likely to Serve as a Promising New Trend in the Epilepsy Market in the Coming Years
Key Players
- Idexx Laboratories Inc
- PBD Biotech Ltd
- Thermo Fisher Scientific Inc
- Innovative Diagnostics SAS
- Neogen Corp
- Enfer Labs
- bioMerieux SA
- Ring Biotechnology Co Ltd
- Bionote Inc
- Shenzhen Bioeasy Biotechnology Co Ltd
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Type
- Progressive Myoclonic Epilepsy
- Reflex Epilepsy
- Generalized Epilepsy
Route of Administration
- Oral
- Parenteral
Treatment Type
- First-Generation Drugs
- Second-Generation Drugs
- Third-Generation Drugs
Age Group
- Adults
- Children